A combinatorial in silico and cellular approach to identify a new class of compounds that target VEGFR2 receptor tyrosine kinase activity and angiogenesis
British Journal of Pharmacology
166 (2), pp 737-748
J. Kankanala, A.M. Latham, A.P. Johnson, S. Homer-Vanniasinkam, C.W.G. Fishwick, S. Ponnambala
Special Offers
Exclusive limited-time pricing on software solutions. Accelerate your research with advanced solutions at unmatched value.